Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bavisant in adult ADHD
NCT00880217Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- May 2009
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bavisant in attention deficit hyperactivity disorder (ADHD), sponsored by Johnson & Johnson. Started May 2009; status: completed.
02
Drugs
bavisant
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00880217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00880217.